HomeCompareTCDA vs EPRT

TCDA vs EPRT: Dividend Comparison 2026

TCDA yields 1851.85% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCDA wins by $4863045258.25M in total portfolio value
10 years
TCDA
TCDA
● Live price
1851.85%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4863045258.31M
Annual income
$4,396,067,798,536,862.00
Full TCDA calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — TCDA vs EPRT

📍 TCDA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCDAEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCDA + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCDA pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCDA
Annual income on $10K today (after 15% tax)
$157,407.41/yr
After 10yr DRIP, annual income (after tax)
$3,736,657,628,756,332.50/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, TCDA beats the other by $3,736,657,628,745,418.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCDA + EPRT for your $10,000?

TCDA: 50%EPRT: 50%
100% EPRT50/50100% TCDA
Portfolio after 10yr
$2431522629.19M
Annual income
$2,198,033,899,274,851.20/yr
Blended yield
90.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

TCDA
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Price Target
$16.00
+14714.8% upside vs current
Range: $16.00 — $16.00
Altman Z
-16.7
Piotroski
1/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCDA buys
0
EPRT buys
0
No recent congressional trades found for TCDA or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCDAEPRT
Forward yield1851.85%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$4863045258.31M$63.4K
Annual income after 10y$4,396,067,798,536,862.00$12,840.73
Total dividends collected$4829695825.56M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$16.00$35.50

Year-by-year: TCDA vs EPRT ($10,000, DRIP)

YearTCDA PortfolioTCDA Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$195,885$185,185.19$11,205$505.18+$184.7KTCDA
2$3,599,787$3,390,190.12$12,672$682.46+$3.59MTCDA
3$62,077,580$58,225,807.67$14,490$930.48+$62.06MTCDA
4$1,004,826,655$938,403,644.40$16,786$1,282.69+$1004.81MTCDA
5$15,271,043,115$14,195,878,594.10$19,753$1,791.56+$15271.02MTCDA
6$217,970,436,268$201,630,420,135.20$23,677$2,541.64+$217970.41MTCDA
7$2,922,911,796,978$2,689,683,430,171.31$29,008$3,672.99+$2922911.77MTCDA
8$36,835,711,310,169$33,708,195,687,401.73$36,463$5,425.08+$36835711.27MTCDA
9$436,427,532,502,759$397,013,321,400,878.75$47,238$8,221.57+$436427532.46MTCDA
10$4,863,045,258,314,815$4,396,067,798,536,862.00$63,385$12,840.73+$4863045258.25MTCDA

TCDA vs EPRT: Complete Analysis 2026

TCDAStock

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Full TCDA Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this TCDA vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCDA vs SCHDTCDA vs JEPITCDA vs OTCDA vs KOTCDA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.